p53 SLP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for p53 SLP, covering 2014-01-07 to 2014-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]